Cargando…
Efficacy of GMI, a fungal immunomodulatory protein, for head and neck cancer patients with chemotherapy-related oral mucositis: An open-labeled prospective single-arm study
BACKGROUND: Cancer patients usually suffer from intensive chemotherapy-related oral mucositis (OM), yet limited effective treatment can rapidly alleviate OM severity. METHODS: This prospective study examined the efficacy of Reishimmune-S containing one fungal immunomodulatory protein, GMI on OM in p...
Autores principales: | Lu, Hsueh-Ju, Li, Che-Hsing, Kang, Yu-Ting, Wu, Chi-Mei, Wu, Chih-Hsien, Ko, Jiunn-Liang, Wu, Ming-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276401/ https://www.ncbi.nlm.nih.gov/pubmed/35482987 http://dx.doi.org/10.1097/MD.0000000000029185 |
Ejemplares similares
-
The Protective Role of GMI, an Immunomodulatory Protein From
Ganoderma microsporum, on 5-Fluorouracil-Induced Oral and
Intestinal Mucositis
por: Li, Che-Hsing, et al.
Publicado: (2019) -
The effect of comprehensive oral care program on oral health and quality of life in patients undergoing radiotherapy for head and neck cancer: A quasi-experimental case-control study
por: Lee, Hye-Ju, et al.
Publicado: (2021) -
Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma
por: Meng, Di, et al.
Publicado: (2021) -
Association between folate intake and risk of head and neck squamous cell carcinoma: An overall and dose–response PRISMA meta-analysis
por: Fan, Chengchao, et al.
Publicado: (2017) -
Oral Mucosal Lesions in Indians From Northeast Brazil: Cross-Sectional Study of Prevalence and Risk Indicators
por: Cury, Patricia Ramos, et al.
Publicado: (2014)